Extract from European Patent Office communication yesterday: For...

  1. RBx
    643 Posts.
    lightbulb Created with Sketch. 1002
    Extract from European Patent Office communication yesterday:

    For the intended grant of the European patent, the bibliographic data are set out below, for information:

    Title of Invention:  ISOFLAVONOID COMPOSITION WITH IMPROVED PHARMACOKINETICS

    Details of the application were updated by Noxopharm on 14 May, as requested by the EPO, as a prelude to the formal grant of patent protection.

    Patent grant will take place when all formalities are complete.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.8¢
Change
0.000(0.00%)
Mkt cap ! $28.63M
Open High Low Value Volume
9.7¢ 9.8¢ 9.5¢ $15.43K 159.9K

Buyers (Bids)

No. Vol. Price($)
1 47773 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.8¢ 47899 1
View Market Depth
Last trade - 16.10pm 12/09/2025 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.